Facet Joint Interventions (Coverage Criteria for Diagnostic and Therapeutic Facet Injections and Radiofrequency Neurotomy)
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.171 alerts
Get alerted when Policy CP.MP.171 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria, coding, and coverage stance for diagnostic and therapeutic facet joint injections and radiofrequency neurotomy for cervical and lumbar spine pain for members of Arizona Complete Health (Centene-affiliated plans).
Pain relief thresholds for diagnostic blocks and radiofrequency criteria updated from >75% to ≥80%; repeat neurotomy interval changed from at least four months to at least six months.
Added requirement that interventions be performed under fluoroscopy or CT guidance and removed select ultrasound CPT codes from supported coding.
Clarified conservative therapy requirements to include ≥ four weeks physical therapy or prescribed home exercise program and specified exceptions for facet joint synovial cysts.
Updated Criteria I.A.1.b.i. regarding physical therapy; removed Criteria I.A.1.b.ii. regarding activity modification and added notation about facet joint synovial cyst in related sections.
Coding and descriptions reviewed.
Medical Necessity Criteria
inv-01: Diagnostic Facet Joint Injection Criteria
Covered when ALL of the following are met:
inv-02: Conventional Radiofrequency Neurotomy Criteria
Covered when ALL of the following are met:
inv-03: Therapeutic Facet Joint Injection Criteria
Covered when ALL of the following are met:
inv-04: Not Medically Necessary Procedures
inv-05: Revised criteria group
Policy criteria updated—see Criteria I.A.1.b.i., I.A.1.c.; I.A.1.b.ii. removed.
Full clinical criteria text available in other policy sections.
Facet joint injections and conventional radiofrequency neurotomy of the thoracic region are not medically necessary because effectiveness has not been established. The policy explicitly states thoracic facet joint injections and thoracic conventional radiofrequency neurotomy are considered not medically necessary and that further well‑designed randomized controlled trials are needed to evaluate effectiveness. Additionally, pulsed radiofrequency neurotomy of the facet joints is considered not medically necessary due to insufficient and low‑quality evidence. Ultrasound‑guided facet injection CPT codes (e.g., 0213T, 0216T) are listed as not supporting coverage and are not accepted for coverage under this policy.
The policy was revised to remove Criterion I.A.1.b.ii. (activity modification). Providers should consult the full policy text for the remaining criteria and explicit exclusions; the document notes that Criteria I.A.1.b.i. (physical therapy) was updated and that a notation regarding facet joint synovial cysts was added under related criteria.
Pulsed radiofrequency neurotomy of the facet joints is considered not medically necessary due to limited and low‑quality evidence and the need for randomized controlled trials. The policy also indicates that facet joint injections and conventional radiofrequency neurotomy of the thoracic region are not medically necessary because effectiveness has not been established. Ultrasound‑guided injection CPT codes (for example, 0213T and 0216T) are explicitly listed as not supporting coverage.
Billing and Code Lists
| 64490 | Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), cervical or thoracic; single level. |
| 64491 | … cervical or thoracic; second level (List separately in addition to code for primary procedure). |
| 64492 | … cervical or thoracic; third and any additional level(s) (List separately in addition to code for primary procedure). |
| 64493 | … lumbar or sacral; single level. |
| 64494 | … lumbar or sacral; second level (List separately in addition to code for primary procedure). |
| 64495 | … lumbar or sacral; third and any additional level(s) (List separately in addition to code for primary procedure). |
| 64633 | Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); cervical or thoracic, single facet joint. |
| 64634 | … cervical or thoracic, each additional facet joint (List separately in addition to code for primary procedure). |
| 64635 | … lumbar or sacral, single facet joint. |
| 64636 | … lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure). |
| 0213T | Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; single level. |
| 0216T | Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; single level. |
Authorization, Documentation, and Billing Guidance
Prior Authorization Required
Prior authorization is required by Arizona Complete Health for diagnostic and therapeutic facet joint injections and conventional radiofrequency neurotomy when the medical necessity criteria in this policy are met. Submit a prior authorization request before performing these procedures to avoid claim denial.
- Applies to diagnostic facet injections, therapeutic facet injections, and conventional radiofrequency neurotomy performed under fluoroscopy or CT guidance.
- Limit of one procedure per visit applies; no more than three spinal levels (unilateral or bilateral) treated at the same session.
Authorization Follows Updated Criteria
Prior authorization decisions will follow the updated clinical criteria (see Criteria I.A.1.b.i. and related sections). If the member meets the revised criteria (for example, updated physical therapy requirements or exceptions for facet joint synovial cyst), include documentation that aligns with the current policy language.
- Reference the updated Criteria I.A.1.b.i. for physical therapy/home exercise documentation and the note regarding facet joint synovial cysts.
- Removal of prior criteria (e.g., I.A.1.b.ii. regarding activity modification) means previously acceptable documentation based on that removed criterion may no longer support authorization.
Policy Changes May Affect Authorization
Policy changes may affect prior authorizations. When criteria are removed or revised, prior authorization may be denied if the required supporting documentation for the current criteria is not provided.
- Example: Removal of Criterion I.A.1.b.ii. (activity modification) may result in denial if providers rely on that documentation instead of the current requirements.
- Always include documentation meeting the current policy effective at time of request; the Health Plan may change, amend, or withdraw policies at any time.
Document Therapy, Response, and Coding
Document adherence to the policy's therapy and coding requirements when submitting prior authorization and claims. Include duration of pain, conservative therapy details, responses to diagnostic injections, and the specific CPT codes used.
- Document pain duration (≥ 3 months) and clinical findings consistent with facet joint pain.
- Document failure of conservative therapy: ≥4 weeks physical therapy or prescribed home exercise program (or documented inability to tolerate), and ≥3 weeks of NSAIDs or documented contraindication/intolerance.
- Include documentation of response to diagnostic controlled facet injections when required (e.g., ≥ 80% relief for radiofrequency neurotomy eligibility; ≥50% relief for repeat therapeutic procedures).
- Support billing with fluoroscopy or CT image-guided CPT codes (e.g., 64490–64495 for facet injections; 64633–64636 for neurotomy) and avoid codes for unsupported guidance methods.
Conservative Therapy Prerequisite
Conservative therapy must be documented before authorization of diagnostic facet injections except in defined exceptions (e.g., facet joint synovial cyst causing nerve root compression with moderate to severe radicular pain and functional limitations).
- At minimum, document ≥ four weeks of physical therapy or a prescribed home exercise program, or document inability to tolerate such therapy.
- Document ≥ three weeks of NSAID therapy or a contraindication/intolerance to NSAIDs.
- If a facet joint synovial cyst is present causing nerve root compression with moderate–severe radicular pain, the physical therapy/home exercise requirement may be waived; document imaging and clinical correlation.
Prerequisites Before Interventional Procedures
inv-27: Documented failure or inability to tolerate conservative measures before diagnostic injections
Documented failure or inability to tolerate conservative measures before diagnostic injections:
inv-28: Documented physical therapy or prescribed home exercise program as specified in updated Criteria I.A.1.b.i.
Documented physical therapy or prescribed home exercise program as specified in updated Criteria I.A.1.b.i.:
Utilization and Repeat Procedure Rules
Guidance and Imaging for Procedures
Perform facet procedures with fluoroscopy or CT guidance
Facet joint injections and radiofrequency neurotomy must be performed under fluoroscopy or CT guidance; document the imaging modality used in the procedure note to meet policy imaging requirements.
- Policy statement: interventions are recommended and required to be performed under fluoroscopy or CT guidance.
- Include image-guidance details in operative report and billing to support covered CPT codes.
Refer to cited imaging guidelines and evidence reviews
The policy references diagnostic imaging guidelines and evidence reviews (ASIPP, CMS LCDs, NASS, Cochrane, and other systematic reviews); consult the full policy references section for detailed guidance on imaging and evidence that informed coverage decisions.
- Key references include ASIPP guidelines, CMS local coverage determinations, NASS guidelines, and Cochrane reviews cited in the policy.
Services Considered Not Medically Necessary
Not covered under this policy are facet joint injections and conventional radiofrequency neurotomy of the thoracic region because effectiveness has not been established. In addition, pulsed radiofrequency neurotomy is not covered due to insufficient evidence. The policy also identifies ultrasound‑guided facet injection CPT codes (including 0213T and 0216T) as not supporting coverage and therefore not covered.
Clinical Background
Facet joints are a common source of chronic axial neck and low back pain. Diagnosis of facet‑mediated pain relies on clinical assessment and confirmation by diagnostic medial branch blocks or facet joint injections, with meaningful temporary pain relief after a controlled diagnostic block serving as the key diagnostic indicator used to select patients for subsequent interventions such as radiofrequency neurotomy.
Terminology and Procedure Definitions
Policy Changes and Review
Annual review: clarified diagnostic criteria; pain relief thresholds standardized from >75% to ≥80%; repeat radiofrequency interval changed from ≥4 months to ≥6 months; removed select ultrasound-guided CPT codes (0214T, 0215T, 0217T, 0218T) from coding table.
Annual review and approval: updated Criteria I.A.1.b.i. regarding physical therapy; noted exceptions for facet joint synovial cyst and removed Criteria I.A.1.b.ii. (activity modification); updated Criteria I.A.1.c.; coding and descriptions reviewed.
Annual review: Updated Criteria I.A.1.b.i. regarding physical therapy and added note about physical therapy or prescribed home exercise for facet joint synovial cyst; removed Criteria I.A.1.b.ii. regarding activity modification; Criteria I.A.1.c. updated; coding and references reviewed and updated.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.